Drug Profile
Peginterferon alpha-2b biosimilar - Virchow Group
Alternative Names: PEG-Inferon; VIPEGLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Virchow Group
- Class Antineoplastics; Antiretrovirals; Antivirals; Immunotherapies; Interferons; Polyethylene glycols; Skin disorder therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis B; Hepatitis C
Most Recent Events
- 15 May 2015 Launched for Hepatitis B in India (SC) before May 2015 (Virchow Group website, May 2015)
- 14 May 2015 Launched for Hepatitis C in India (SC) before May 2015 (Virchow Group website, May 2015)